This work broadens current literature regarding the functions of SWI/SNF subunits in controlling ribosome biogenesis, and suggests that KPNB1/CNBP/SMARCC2 axis‐mediated ribosome biogenesis and M2 macrophage polarization is a valuable therapeutic target for tumours. The gene discussed is SMARCC2; the disease is neoplasm.